Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”

Descripción del Articulo

I read with great interest a recent study by Poterico and Mestanza who described mutations in 30 SARS‐CoV‐2 genomes from South American countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru). Next‐generation sequencing (NGS) technologies have accelerated genomic and metagenomic studies pr...

Descripción completa

Detalles Bibliográficos
Autor: Romero P.E.
Formato: artículo
Fecha de Publicación:2021
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/2423
Enlace del recurso:https://hdl.handle.net/20.500.12390/2423
https://doi.org/10.1002/jmv.26122
Nivel de acceso:acceso abierto
Materia:Virology
Infectious Diseases
http://purl.org/pe-repo/ocde/ford#3.03.09
id CONC_90f688ca68c47edf1851464a473d9999
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/2423
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
spelling Publicationrp01708600Romero P.E.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2021https://hdl.handle.net/20.500.12390/2423https://doi.org/10.1002/jmv.261222-s2.0-85086467449I read with great interest a recent study by Poterico and Mestanza who described mutations in 30 SARS‐CoV‐2 genomes from South American countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru). Next‐generation sequencing (NGS) technologies have accelerated genomic and metagenomic studies providing affordable tools to obtain pathogen genomes and improving diagnosis and surveillance efforts. However, many downstream analyses after assembling the genomes are impacted by low‐quality sequences and sequence contamination, which could lead to wrong conclusion.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengJohn Wiley and Sons IncJournal of Medical Virologyinfo:eu-repo/semantics/openAccessVirologyInfectious Diseases-1http://purl.org/pe-repo/ocde/ford#3.03.09-1Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”info:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC20.500.12390/2423oai:repositorio.concytec.gob.pe:20.500.12390/24232024-05-30 16:08:04.635http://purl.org/coar/access_right/c_14cbinfo:eu-repo/semantics/closedAccessmetadata only accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="e08152fc-d444-4dd3-84ee-1e63b068f5eb"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”</Title> <PublishedIn> <Publication> <Title>Journal of Medical Virology</Title> </Publication> </PublishedIn> <PublicationDate>2021</PublicationDate> <DOI>https://doi.org/10.1002/jmv.26122</DOI> <SCP-Number>2-s2.0-85086467449</SCP-Number> <Authors> <Author> <DisplayName>Romero P.E.</DisplayName> <Person id="rp01708" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>John Wiley and Sons Inc</DisplayName> <OrgUnit /> </Publisher> </Publishers> <Keyword>Virology</Keyword> <Keyword>Infectious Diseases</Keyword> <Abstract>I read with great interest a recent study by Poterico and Mestanza who described mutations in 30 SARS‐CoV‐2 genomes from South American countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru). Next‐generation sequencing (NGS) technologies have accelerated genomic and metagenomic studies providing affordable tools to obtain pathogen genomes and improving diagnosis and surveillance efforts. However, many downstream analyses after assembling the genomes are impacted by low‐quality sequences and sequence contamination, which could lead to wrong conclusion.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
dc.title.none.fl_str_mv Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
title Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
spellingShingle Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
Romero P.E.
Virology
Infectious Diseases
http://purl.org/pe-repo/ocde/ford#3.03.09
title_short Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
title_full Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
title_fullStr Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
title_full_unstemmed Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
title_sort Comment on “Genetic variants and source of introduction of SARS-CoV-2 in South America”
author Romero P.E.
author_facet Romero P.E.
author_role author
dc.contributor.author.fl_str_mv Romero P.E.
dc.subject.none.fl_str_mv Virology
topic Virology
Infectious Diseases
http://purl.org/pe-repo/ocde/ford#3.03.09
dc.subject.es_PE.fl_str_mv Infectious Diseases
dc.subject.ocde.none.fl_str_mv http://purl.org/pe-repo/ocde/ford#3.03.09
description I read with great interest a recent study by Poterico and Mestanza who described mutations in 30 SARS‐CoV‐2 genomes from South American countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru). Next‐generation sequencing (NGS) technologies have accelerated genomic and metagenomic studies providing affordable tools to obtain pathogen genomes and improving diagnosis and surveillance efforts. However, many downstream analyses after assembling the genomes are impacted by low‐quality sequences and sequence contamination, which could lead to wrong conclusion.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/2423
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1002/jmv.26122
dc.identifier.scopus.none.fl_str_mv 2-s2.0-85086467449
url https://hdl.handle.net/20.500.12390/2423
https://doi.org/10.1002/jmv.26122
identifier_str_mv 2-s2.0-85086467449
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal of Medical Virology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv John Wiley and Sons Inc
publisher.none.fl_str_mv John Wiley and Sons Inc
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1844883040411582464
score 13.413352
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).